{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [{"AbstractText": ["Ama\u00e7: Bu \u00e7al\u0131\u015fman\u0131n amac\u0131 yeni bitkisel bir \u00fcr\u00fcn olan KL-21\u2019in [Naturin do\u011fal \u00fcr\u00fcnler \u015firketi (\u0130zmir, T\u00fcrkiye) taraf\u0131ndan \u00fcretilen] 232B4 kronik lenfostik l\u00f6semi (KLL) h\u00fccreleri \u00fczerindeki sitotoksik ve apoptotik etkilerinin ara\u015ft\u0131r\u0131lmas\u0131d\u0131r. Ayr\u0131ca, KL-21\u2019in BEAS-2B sa\u011fl\u0131kl\u0131 insan bron\u015fial epitelyum h\u00fccreleri \u00fczerindeki sitotoksik etkisine de bak\u0131lm\u0131\u015ft\u0131r. Gere\u00e7 ve Y\u00f6ntemler: KL-21\u2019in sitotoksik etkisine MTT h\u00fccre \u00e7o\u011falma testiyle bak\u0131lm\u0131\u015ft\u0131r. Kaspaz-3 enzim aktivitesindeki ve mitokondri membran potansiyelindeki de\u011fi\u015fimlere s\u0131ras\u0131yla kaspaz-3 kolorimetrik testi ve JC-1 boyas\u0131na dayal\u0131 bir y\u00f6ntem kullan\u0131larak bak\u0131lm\u0131\u015ft\u0131r. Apoptotik h\u00fccre pop\u00fclasyonunu belirlemek amac\u0131yla Anneksin 5-FITC/PI ikili boyama y\u00f6ntemi kullan\u0131lm\u0131\u015ft\u0131r. KL-21\u2019in KLL h\u00fccrelerinin h\u00fccre siklusu \u00fczerindeki etkilerine ak\u0131m sitometresi ile bak\u0131lm\u0131\u015ft\u0131r. Bulgular: KL-21\u2019in KLL h\u00fccrelerinin \u00e7o\u011falmas\u0131 \u00fczerine etkisi zamana ve doza ba\u011f\u0131ml\u0131 olarak artm\u0131\u015ft\u0131r. Bununlar beraber, KL-21\u2019in \u00f6zellikle y\u00fcksek konsantrasyonlarda KLL h\u00fccreleri ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda BEAS-2B h\u00fccreleri \u00fczerinde daha az sitotoksik etki g\u00f6sterdi\u011fi saptanm\u0131\u015ft\u0131r. Anneksin-5/PI ikili boyamas\u0131 232B4 h\u00fccrelerinde apoptotik h\u00fccre pop\u00fclasyonunun artt\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015ftir. KL-21\u2019in artan konsantrayonlar\u0131 kaspaz-3 enzim aktivitesini artt\u0131rm\u0131\u015f ve mitokondri membran potansiyelindeki kay\u0131plar\u0131 ind\u00fcklemi\u015ftir. KL-21 1 mg/ml konsantrasyonuna kadar G0/G1 faz\u0131ndaki h\u00fccrelerin y\u00fczdesinde k\u00fc\u00e7\u00fck art\u0131\u015flara ve S faz\u0131ndaki h\u00fccre pop\u00fclasyonunda ise azalmalara neden olmaktad\u0131r. En y\u00fcksek konsantrasyonda ise h\u00fccrelerin b\u00fcy\u00fck bir \u00e7o\u011funlu\u011fu G0/G1 faz\u0131nda birikmi\u015ftir. Sonu\u00e7: Elde edilen sonu\u00e7lar, KL-21\u2019in 232B4 KLL h\u00fccreleri \u00fczerinde b\u00fcy\u00fcmeyi inhibe edici bir etkisi oldu\u011funu g\u00f6stermi\u015ftir. Ayr\u0131ca, K-21 apoptozu ind\u00fcklemekte ve G0/G1 faz\u0131nda h\u00fccre siklusunun tutulumuna neden olmaktad\u0131r."]}], "PMID": "26316479", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "23"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "ELocationID": ["10.4274/tjh.2013.0381"], "Language": ["eng"], "Journal": {"ISSN": "1308-5263", "JournalIssue": {"Volume": "32", "Issue": "2", "PubDate": {"Year": "2015", "Month": "Jun"}}, "Title": "Turkish journal of haematology : official journal of Turkish Society of Haematology", "ISOAbbreviation": "Turk J Haematol"}, "ArticleTitle": "A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells.", "Pagination": {"StartPage": "118", "EndPage": "126", "MedlinePgn": "118-26"}, "Abstract": {"AbstractText": ["The aims of this study were to examine the cytotoxic and apoptotic effects of KL-21, a novel plant product (produced by Naturin Natural Products, \u0130zmir, Turkey), on 232B4 chronic lymphocytic leukemia (CLL) cells and to determine the cytotoxic effects on healthy BEAS-2B human bronchial epithelial cells.", "The cytotoxic effect of KL-21 was determined by MTT cell proliferation assay. Changes in caspase-3 enzyme activity were measured using the caspase-3 colorimetric assay. Changes in mitochondrial membrane potential were determined using the JC-1 dye-based method. Annexin V-FITC/PI double staining was performed to measure the apoptotic cell population. Effects of KL-21 on cell cycle profiles of CLL cells were investigated by flow cytometry.", "We detected time- and concentration-dependent increases in the cytotoxic effect of KL-21 on 232B4 CLL cells. However, we also showed that, especially at higher concentrations, KL-21 was less cytotoxic towards BEAS-2B healthy cells than towards CLL cells. Annexin-V/PI double staining results showed that the apoptotic cell population increased in 232B4 cells. Increasing concentrations of KL-21 increased caspase-3 enzyme activity and induced loss of mitochondrial membrane potential. KL-21 administration resulted in small increases in the percentage of the cells in the G0/G1 phase while it decreased the S phase cell population up to 1 mg/mL. At the highest concentration, most of the cells accumulated in the G0/G1 phase.", "KL-21 has a growth-inhibitory effect on 232B4 CLL cells. KL-21 causes apoptosis and cell cycle arrest at G0/G1."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Adan G\u00f6kbulut", "ForeName": "Aysun", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ya\u015far", "ForeName": "Mustafa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "\u0130zmir Institute of Technology Faculty of Science, Department of Molecular Biology and Genetics, \u0130zmir, Turkey Phone: +90 232 750 73 15 E-mail: ybaran@gmail.com."}], "LastName": "Baran", "ForeName": "Yusuf", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Turkey", "MedlineTA": "Turk J Haematol", "NlmUniqueID": "9606065", "ISSNLinking": "1300-7777"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "KL-21 plant preparation"}, {"RegistryNumber": "0", "NameOfSubstance": "Neoplasm Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP3 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Biological Products"}, {"QualifierName": ["analysis"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Leukemia, Lymphocytic, Chronic, B-Cell"}, {"QualifierName": ["drug effects"], "DescriptorName": "Membrane Potential, Mitochondrial"}, {"QualifierName": ["analysis"], "DescriptorName": "Neoplasm Proteins"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "<b>Conflict of Interest Statement</b>. Dr. Yusuf Baran was on the advisory board of Naturin Natural Products from 15.09.2011 to 15.01.2012. He designed and conducted the experiments for the examination of effects of natural products on cancer and healthy cells."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 2003;21:841\u2013894.", "ArticleIdList": ["12615894"]}, {"Citation": "Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J Clin Oncol. 2008;26:4497\u20134503.", "ArticleIdList": ["18662968"]}, {"Citation": "Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med. 1995;333:1052\u20131057.", "ArticleIdList": ["7675049"]}, {"Citation": "Veliz M, Pinilla-Ibarz J. Role of ofatumumab in treatment of chronic lymphocytic leukemia. J Blood Med. 2011;2:71\u201377.", "ArticleIdList": ["PMC3262343", "22287865"]}, {"Citation": "Byrd JC, Stilgenbauer S, Flinn IW. Chronic lymphocytic leukemia. Hematology. 2004;2004:163\u2013183.", "ArticleIdList": ["15561682"]}, {"Citation": "Flinn IW, Grever MR. Chronic lymphocytic leukemia. Cancer Treat Rev. 1996;96:1\u201313.", "ArticleIdList": ["8625329"]}, {"Citation": "Hainsworth JD, Litchy S, Barton JH, Houston GA, Hermann RC, Bradof JE. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network. J Clin Oncol. 2003;21:1746\u20131751.", "ArticleIdList": ["12721250"]}, {"Citation": "O\u2019Brien SM, Kantarjian HM, Thomas DA, Cortes J, Giles FJ, Wierda WG, Koller CA, Ferrajoli A, Browning M, Lerner S, Albitar M, Keating MJ. Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia. Cancer. 2003;98:2657\u20132663.", "ArticleIdList": ["14669286"]}, {"Citation": "Dreger P, Montserrat E. Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia. Leukemia. 2002;16:985\u2013992.", "ArticleIdList": ["12040430"]}, {"Citation": "Esteve J, Villamor N, Colomer D, Cervantes F, Campo E, Carreras E, Montserrat E. Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status. Leukemia. 2001;5:445\u2013451.", "ArticleIdList": ["11237069"]}, {"Citation": "Berdeja JG, Jones RJ, Zahurak ML, Piantadosi S, Abrams RA, Borowitz MJ, Vogelsang GB, Noga SJ, Ambinder RF, Flinn IW. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biol Blood Marrow Transplant. 2001;7:561\u2013567.", "ArticleIdList": ["11760088"]}, {"Citation": "Veliz M, Pinilla-Ibarz J. Treatment of relapsed or refractory chronic lymphocytic leukemia. Cancer Control. 2012;19:37\u201353.", "ArticleIdList": ["22143061"]}, {"Citation": "Podhorecka M, Halicka D, Klimek P, Kowal M, Chocholska S, Dmoszynska A. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. Ann Hematol. 2011;90:173\u2013183.", "ArticleIdList": ["PMC3018253", "20714724"]}, {"Citation": "Russo M, Spagnuolo C, Volpe S, Mupo A, Tedesco I, Russo GL. Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. Br J Cancer. 2010;103:642\u2013648.", "ArticleIdList": ["PMC2938248", "20648016"]}, {"Citation": "Baran Y, Bielawski J, Gunduz U, Ogretmen B. Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation. J Cancer Res Clin Oncol. 2011;137:1535\u20131544.", "ArticleIdList": ["21833718"]}, {"Citation": "Avc\u0131 \u00c7B, G\u00fcnd\u00fcz C, Baran Y, \u015eahin F, Y\u0131lmaz S, Dogan ZO, Saydam G. Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells. J Cancer Res Clin Oncol. 2011;137:41\u201347.", "ArticleIdList": ["20221636"]}, {"Citation": "Brown JR. The treatment of relapsed refractory chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2011;2011:110\u2013118.", "ArticleIdList": ["22160021"]}, {"Citation": "Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005;106:690\u2013697.", "ArticleIdList": ["15802533"]}, {"Citation": "Gokbulut AA, Apohan E, Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology. 2013;18:144\u2013150.", "ArticleIdList": ["23432965"]}, {"Citation": "K\u00f6nig A, Schwartz GK, Mohammad RM, Al-Katib R, Gabrilove JL. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. Blood. 1997;90:4307\u20134312.", "ArticleIdList": ["9373241"]}, {"Citation": "Csupor-L\u00f6ffler B, Hajd\u00fa Z, Zupk\u00f3 I, R\u00e9thy B, Falkay G, Forgo P, Hohmann J. Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s. l. on cultured human tumour cell lines. Phytother Res. 2009;23:672\u2013676.", "ArticleIdList": ["19107850"]}, {"Citation": "Akbay P, Basaran AA, Undeger U, Basaran N. In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L. Phytother Res. 2003;17:34\u201337.", "ArticleIdList": ["12557244"]}, {"Citation": "Yoshinobu Y. Antitumor activity of crude protein extracted from Equisetum arvense LINN\u2019E. Journal of Analytical Bio-Science. 1992;22:421\u2013424."}, {"Citation": "Asgarpanah J, Roohi E. Phytochemistry and pharmacological properties of Equisetum arvense L. J Med Plants Res. 2012;6:3689\u20133693."}, {"Citation": "Jimenez-Arellanes A, Martinez R, Garc\u00eda R, Leon-Diaz R, Luna-Herrera J, Molina-Salinas G, Said-Fern\u00e1ndez S. Thymus vulgaris as a potencial source of antituberculous compounds. Pharmacologyonline. 2006;3:569\u2013574."}, {"Citation": "Kienle G. Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther. 2010;9:142\u2013157.", "ArticleIdList": ["20483874"]}, {"Citation": "Sabova L, Pil\u00e1tov\u00e1 M, Szilagyi K, Sabo R, Mojzis J. Cytotoxic effect of mistletoe (Viscum album L) extract on Jurkat cells and its interaction with doxorubicin. Phytother Res. 2010;24:365\u2013368.", "ArticleIdList": ["19610041"]}, {"Citation": "Singh R, Sharma PK, Malviya R. Pharmacological properties and ayurvedic value of Indian buch plant (Acorus calamus): a short review. Advances in Biological Research. 2011;5:145\u2013154."}, {"Citation": "Demir H, A\u00e7\u0131k L, Bali EB, Ko\u00e7 LY, Kaynak G. Antioxidant and antimicrobial activities of Solidago virgaurea extracts. Afr J Biotechnol. 2009;8:274\u2013279."}, {"Citation": "Gross SC, Goodarzi G, Watabe M, Bandyopadhyay S, Pai SK, Watabe K. Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model. Nutr Cancer. 2002;43:76\u201381.", "ArticleIdList": ["12467138"]}, {"Citation": "Davis-Searles PR, Nakanishi Y, Kim NC, Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R, Kroll DJ. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res. 2005;65:4448\u20134457.", "ArticleIdList": ["15899838"]}, {"Citation": "Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M. The efficacy of Silybum marianum (L) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20:1036\u20131039.", "ArticleIdList": ["17072885"]}, {"Citation": "Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci India. 2004;87:44\u201353."}, {"Citation": "Al-Sereitia MR, Abu-Amerb KM, Sena P. Pharmacology of rosemary (Rosmarinus officinalis Linn) and its therapeutic potentials. Indian J Exp Biol. 1999;37:124\u2013131.", "ArticleIdList": ["10641130"]}, {"Citation": "G\u00f6ren AC, Top\u00e7u G, Bilsel G, Bilsel M, Aydo\u011fmus Z, Pezzuto JM. The chemical constituents and biological activity of essential oil of Lavandula stoechasssps toechas. Z Naturforsch. 2002;57c:797\u2013800.", "ArticleIdList": ["12440714"]}, {"Citation": "Neves JM, Matos C, Moutinho C, Queiroz E, Gomes LR. Ethnopharmacological notes about ancient uses of medicinal plants in Tras-os-Montes (northern of Portugal) J Ethnopharmacol. 2009;124:270\u2013283.", "ArticleIdList": ["19409473"]}, {"Citation": "Manske RHF. The alkaloids of fumariaceous plants: xviii. Fumaria officinalis L. Can J Res. 1938;16:438\u2013444."}, {"Citation": "Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, Romero AE, Pullin MJ, Kornienko A, Lowrey TK, Slambrouck SV, Steelant WF. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol. 2008;32:1085\u20131090.", "ArticleIdList": ["18425335"]}, {"Citation": "Hu C, Kitts DD. Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. J. Agric Food Chem. 2003;51:301\u2013310.", "ArticleIdList": ["12502425"]}, {"Citation": "Chen CJ, Deng AJ, Liu C, Shi R, Qin HL, Wang AP. Hepatoprotective activity of Cichorium endivia Lextract and its chemical constituents. Molecules. 2011;16:9049\u20139066.", "ArticleIdList": ["PMC6264765", "22033140"]}, {"Citation": "Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006;96:660\u2013666.", "ArticleIdList": ["17010224"]}, {"Citation": "Mirzaei M. Treatment of natural tropical theileriosis with the extract of the plant Peganum harmala. Korean J Parasitol. 2007;45:267\u2013271.", "ArticleIdList": ["PMC2532620", "18165708"]}, {"Citation": "Lamchouri F, Settaf A, Cherrah Y, Zemzami M, Lyoussi B, Zaid A, Atif N, Hassar M. Antitumour principles from Peganum harmala seeds. Therapie. 1999;54:753\u2013758.", "ArticleIdList": ["10709452"]}, {"Citation": "Pepeljnjak S, Kosalec I, Kalodera Z, Blazevic N. Antimicrobial activity of juniper berry essential oil (Juniperus communis L, Cupressaceae). Acta Pharm. 2005;55:417\u2013422.", "ArticleIdList": ["16375831"]}, {"Citation": "Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299\u2013305.", "ArticleIdList": ["12722128"]}, {"Citation": "Silva BA, Ferreres F, Malva JO, Dias ACP. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food Chem. 2005;90:157\u2013167."}, {"Citation": "Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesey JF, Jordan SA. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharmaceut Sci. 2004;72:265\u2013273.", "ArticleIdList": ["15367385"]}, {"Citation": "Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003;74:863\u2013866.", "ArticleIdList": ["PMC1738567", "12810768"]}, {"Citation": "Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev. 2003;23:519\u2013534.", "ArticleIdList": ["12710022"]}, {"Citation": "Salminen A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J. Terpenoids: natural inhibitors of NF-B signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci. 2008;65:2979\u20132999.", "ArticleIdList": ["18516495"]}, {"Citation": "Rabi T, Bishayee A. Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat. 2009;115:223\u2013239.", "ArticleIdList": ["18636327"]}, {"Citation": "Vandenbogaerde AL, Witte PA., de Hypericin as a natural photosensitizer with cytotoxic and antitumor effects. Phytother Res. 1996;10:S150\u2013S152."}, {"Citation": "Roscetti G, Franzese O, Comandini A, Bonmassar E. Cytotoxic activity of Hypericum perforatum L on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res. 2004;18:66\u201372.", "ArticleIdList": ["14750204"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "9", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "6", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26316479", "PMC4451479", "10.4274/tjh.2013.0381"]}}], "PubmedBookArticle": []}